PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887032
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1887032
The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.
MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.
North America Leads the Market in 2024
North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.
Market Size Overview (2024-2032)
The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.
Key Country Highlights
United States
The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.
Japan
An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.
China
With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.
Europe
Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.
Market Dynamics
Drivers - Rising Chronic Conditions
Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.
Restraints - High Cost of MIS Technologies
Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.
Opportunities - Growth of Ambulatory Surgical Centers
With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.
Challenges - Shortage of Skilled Surgeons
The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.
Market Trends
Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.
Competitive Landscape
The market is dominated by industry leaders such as:
These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.
Recent developments include:
The global minimally invasive surgery (MIS) devices market continues to gain momentum as healthcare systems increasingly shift toward procedures that reduce recovery time, minimize trauma, and enhance surgical precision. According to the 2024 industry assessment, the MIS devices market was valued at USD 19.07 billion in 2024, driven by rising adoption of MIS procedures across cardiology, orthopedics, gynecology, and gastrointestinal specialties. The market is expected to reach USD 20.27 billion in 2025 and expand significantly to USD 34.93 billion by 2032, exhibiting a strong CAGR of 8.1% from 2025 to 2032.
MIS devices-including laparoscopic tools, endoscopes, robotic-assisted systems, inflation devices, navigation systems, and specialized surgical instruments-enable surgeons to perform complex interventions through small incisions or natural orifices, reducing pain, infection risk, and hospital stays.
North America Leads the Market in 2024
North America dominated the global minimally invasive surgery devices market in 2024 with a 40.27% share, equivalent to USD 7.68 billion. This leadership stems from well-established healthcare infrastructure, high surgical volumes, widespread robotic surgery adoption, and favorable reimbursement policies for MIS procedures. The U.S., with more than 6,300 Medicare-certified Ambulatory Surgical Centers (ASCs) by 2024, continues to drive regional demand for laparoscopic and robotic solutions.
Market Size Overview (2024-2032)
The combination of rising chronic disease incidence, aging populations, and advancements in surgical technologies continues to propel the market forward.
Key Country Highlights
United States
The U.S. leads globally in MIS procedure volume across orthopedic, cardiology, and gastrointestinal applications. Extensive insurance coverage, major surgical robot installations, and strong presence of Medtronic, Johnson & Johnson, and Intuitive Surgical fuel U.S. market strength.
Japan
An aging population and strong robotics investment drive rapid adoption of robotic-assisted laparoscopic and endoscopic surgeries. Hospitals and academic centers increasingly integrate next-generation MIS platforms.
China
With 297 million individuals aged 60+ in 2023, chronic conditions continue to rise, driving MIS demand. Investments in robotic platforms and expanding tertiary care hospitals support broad MIS adoption.
Europe
Countries such as the U.K. and Germany show strong momentum in robotic-assisted surgeries. The U.K.'s first pediatric robotic surgery in early 2025 reflects the region's advanced surgical innovation capabilities.
Market Dynamics
Drivers - Rising Chronic Conditions
Chronic diseases such as cardiovascular disorders, cancer, diabetes, and obesity are driving MIS procedure volumes. With 620 million people worldwide living with heart and circulatory diseases (British Heart Foundation, 2025), the need for minimally invasive interventions continues expanding. Globally, over 4 million arthroscopic knee surgeries are performed annually, highlighting high orthopedic MIS demand.
Restraints - High Cost of MIS Technologies
Advanced MIS tools-especially robotic systems-require heavy investment. Systems like the Da Vinci Surgical System cost around USD 2 million, excluding maintenance and training, limiting adoption in smaller and rural hospitals.
Opportunities - Growth of Ambulatory Surgical Centers
With 6,300+ Medicare-certified ASCs in the U.S. (2024), the shift of high-volume MIS procedures to outpatient settings creates strong demand for imaging, navigation, and minimally invasive tools.
Challenges - Shortage of Skilled Surgeons
The U.S. alone faces a projected shortage of 15,800-30,200 surgeons by 2036, affecting MIS capacity and slowing global adoption.
Market Trends
Technological advancements-including robotic-assisted platforms, AI-guided tools, 3D visualization, and miniaturized endoscopes-continue to redefine MIS standards. Medtronic's FDA submission of the Hugo RAS system, Intuitive Surgical's da Vinci 5 clearance in 2024, and innovations in single-port surgery demonstrate the rapid evolution of the field.
Competitive Landscape
The market is dominated by industry leaders such as:
These companies drive innovation through new launches, AI-integrated surgical solutions, and expansions in robotic surgery systems.
Recent developments include:
Segmentation By Type
By Application
By End-user
By Geography